<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01241877</url>
  </required_header>
  <id_info>
    <org_study_id>MEC 10-3-068</org_study_id>
    <nct_id>NCT01241877</nct_id>
  </id_info>
  <brief_title>Astaxanthin Supplementation in Cyclists</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background of the study:

      Astaxanthin has been shown to be a powerfull anti-oxidant. Health benefits have been shown in
      animals and humans. Exercise enhancing effects have been shown in animals via enhancement of
      fat oxidation. We want to examine the effects of 4 weeks of astaxanthin supplementation on
      fat oxidation and cycling performance in trained cyclists

      Objective of the study:

      To test the hypothesis that 4 weeks supplementation with astaxanthin will improve fat
      oxidation and improve exercise performance in trained cyclists

      Study design:

      Double blind, placebo controlled study.

      Study population:

      Well trained cyclists between 18-30 years old

      Intervention (if applicable):

      astaxanthin (20 mg/day) or placebo for 4 weeks

      Primary study parameters/outcome of the study:

      performance on a time trial after 90 min steady state exercise.

      Secundary study parameters/outcome of the study (if applicable):

      substrate use plasma glucose plasma lactate plasma free fatty acid plasma astaxanthin

      Nature and extent of the burden and risks associated with participation, benefit and group
      relatedness (if applicable):

      The risks involved in participating in this experiment are minimal. Astaxanthin has been
      shown to be safe. Insertion of the catheters in a vein is comparable to a normal blood draw
      and the only risk is of a small local haematoma.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <primary_completion_date type="Anticipated">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time trial performance</measure>
    <time_frame>4 weeks</time_frame>
    <description>time trial performance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>substrate use</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Athletic Performance</condition>
  <arm_group>
    <arm_group_label>astaxanthin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>astaxanthin</intervention_name>
    <description>astaxanthin</description>
    <arm_group_label>astaxanthin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Male

          -  Age between 18 and 30 years

          -  Endurance trained (≥3 sessions of endurance exercise per week)

          -  VO2 max ≥ 50 ml/kg/min

          -  Training history of more than one year of ≥3 sessions of endurance exercise per week

          -  BMI &lt;25 kg/m2

        Exclusion Criteria:

          -  Use of medication

          -  Smoking
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Peter Res, MSc</last_name>
    <phone>+3143381383</phone>
    <email>peter.res@maastrichtuniversity.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maastricht University</name>
      <address>
        <city>Maastricht</city>
        <state>LI</state>
        <zip>6229</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Res, MSc</last_name>
      <phone>+3143381383</phone>
      <email>peter.res@maastrichtuniversity.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2010</study_first_submitted>
  <study_first_submitted_qc>November 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2010</study_first_posted>
  <last_update_submitted>April 19, 2011</last_update_submitted>
  <last_update_submitted_qc>April 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2011</last_update_posted>
  <responsible_party>
    <name_title>Peter Res</name_title>
    <organization>MUMC</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

